Ocutheia
1 known investors
Ocutheia is a therapeutics developer creating treatments for age-related macular degeneration by targeting metabolic dysfunction in photoreceptors. Its approach addresses a molecular target upstream of validated mechanisms, with potential applications in the retina and beyond the eye.
Investors · 1
Frequently asked questions
- What does Ocutheia do?
- Ocutheia is a therapeutics developer creating treatments for age-related macular degeneration by targeting metabolic dysfunction in photoreceptors. Its approach addresses a molecular target upstream of validated mechanisms, with potential applications in the retina and beyond the eye.
- Who are Ocutheia's investors?
- Ocutheia's investors include Michigan Rise.